Slides from NVS R&D Investor Day today CEO overview (29 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/3-paving-our-future-in-science-based-innovation.pdf Mark Fishman, head of research (35 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/4-changing-the-practice-of-medicine.pdf Tim Wright, head of development (47 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/5-focusing-on-patients-following-the-science.pdf Oncology research, Barbara Weber, SVP (29 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/6-bridging-science-and-patients.pdf Oncology development, Alessandro Rivera, EVP (29 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/7-maximizing-the-pipeline-to-deliver-innovative-treatments.pdf Oncology growth strategies, Herve Hoppenot, President (20 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/8-strategy-for-growth.pdf Wrapup by David Epstein, head of pharmaceuticals division (24 pages): http://www.novartis.com/downloads/investors/event-calendar/2012/9-turning-rd-excellence-into-commercial-success.pdf